/PRNewswire/ OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec") today announced that it is the recipient of the 2022 Vanguard Award.
StockNews.com started coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a note issued to investors on Saturday. The brokerage set a “sell” rating on the biotechnology company’s stock. A number of other research analysts also recently issued reports on ONCS. BTIG Research cut their price objective on OncoSec Medical from $10.00 to […]
OncoSec Medical (NASDAQ:ONCS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Tuesday, Zacks.com reports. According to Zacks, “OncoSec Medical Incorporated is a biomedical company engaged in the designing, development and commercialization of therapeutic oncology products. It also develops novel OMS […]